Philips Incisive CT
Philips Healthcare (Suzhou) Co., Ltd. • Radiology • 04/27/2022
Device Purpose
The Philips Incisive CT is a whole-body X-ray computed tomography system designed for comprehensive diagnostic imaging across all patient ages, encompassing head, body, cardiac, and vascular applications, as well as low-dose lung cancer screening. It utilizes a continuously rotating x-ray tube and multi-slice detector array for data acquisition, with computer reconstruction to generate cross-sectional images, and integrates advanced features like deep learning-based image enhancement and automated patient positioning to improve image quality and operational workflow.
Summary
The Philips Incisive CT is an advanced X-ray computed tomography system engineered to generate detailed cross-sectional images of the head and body for comprehensive diagnostic evaluation in patients of all ages. Its operational science relies on a continuously rotating gantry housing an X-ray tube and a multi-slice detector array. This assembly collects X-ray transmission data from various angles and planes around the patient, which is then processed via sophisticated computer algorithms to reconstruct images. The system comprises essential components such as the gantry (with a 72cm bore and providing a 50cm scan field of view), a patient support couch for precise positioning, and an operator's console that facilitates image acquisition, display, analysis, and data management, including post-processing capabilities for various image views. The device is indicated for a broad spectrum of applications, including head, whole-body, cardiac, and vascular CT imaging, and significantly, it supports low-dose CT lung cancer screening protocols for the early detection of pulmonary nodules. Key technological characteristics include its ability to differentiate between high-density tissues like bone and soft tissues, and various scan modes such as axial and helical. This model incorporates several advancements, including a faster minimum scan time (0.35 seconds per 360° rotation), enhanced display resolution, and specialized software features such as "Precise Image" utilizing deep learning for noise reduction and improved low-contrast detectability, "Precise Cardiac" for motion-compensated cardiac imaging, "Precise Position" for automated camera-based patient setup, "Precise Intervention" for guided procedures, and "Direct Results" and "Parallel Workflow" to optimize clinical efficiency.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the 'Precise Image' deep learning neural network for noise reduction compare in diagnostic accuracy and image quality to traditional filtered back projection, particularly at significantly reduced radiation doses?; What is the quantitative impact of the faster gantry rotation speed (0.35s) on reducing motion artifacts in cardiac and pediatric imaging compared to the predicate's 0.42s rotation?; Can the 'Precise Position' camera-based automated patient positioning system demonstrate improved consistency and accuracy in scan setup, potentially leading to reduced scan times or operator variability?; For the 'Precise Intervention' feature, what level of accuracy does it provide in guiding needle placement, and how does it integrate with existing interventional workflows and tools?; Given the expanded capabilities, including advanced features like 'Precise Cardiac' and 'Dual Energy,' what are the specific training requirements for technologists and radiologists to ensure optimal and safe utilization of the Philips Incisive CT?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, HBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly